Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WST-057 in HIV-Associated Distal Sensory Polyneuropathy
NCT05005078Phase 2Completed
- Sponsor
- WinSanTor Inc.
- Start
- Feb 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pirenzepine in HIV-associated distal sensory polyneuropathy (HIV-DSP), sponsored by WinSanTor Inc.. Started Feb 2022; status: completed.
02
Drugs
pirenzepine
03
Conditions
HIV-associated distal sensory polyneuropathy (HIV-DSP)
Beyond the preview
Go deeper on NCT05005078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05005078.